Silvia Menegon

Turin, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

In vitro generation of primary cultures of human hyalocytes.

In vitro generation of primary cultures of human hyalocytes.

Journal: Molecular vision
Published: May 22, 2019

A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits.

A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits.

Journal: Cancer research
Published: April 12, 2019

Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.

Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.

Journal: Neoplasia (New York, N.Y.)
Published: November 30, 2017

The Dual Roles of NRF2 in Cancer.

The Dual Roles of NRF2 in Cancer.

Journal: Trends in molecular medicine
Published: April 07, 2016

A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis.

A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis.

Journal: Oncotarget
Published: March 03, 2016

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Journal: Oncogene
Published: February 01, 2016

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.

Journal: Oncotarget
Published: January 15, 2016

The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival.

The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival.

Journal: Journal of hepatology
Published: June 05, 2015

Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis.

Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis.

Journal: Hepatology (Baltimore, Md.)
Published: November 28, 2014

Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats.

Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats.

Journal: Hepatology (Baltimore, Md.)
Published: June 05, 2014

SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients.

SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients.

Journal: Scientific reports
Published: May 15, 2014

MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC).

MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC).

Journal: Hepatology (Baltimore, Md.)
Published: February 18, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026